)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
NeoGenomics
NeoGenomics (NEO) investor relations material
NeoGenomics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary17 Feb, 2026
Executive summary
Achieved record Q4 revenue of $190M, up 11% year-over-year, and full-year revenue of $727M, up 10%, driven by strong clinical and NGS growth, and ten consecutive quarters of positive adjusted EBITDA.
Clinical revenue grew 16% year-over-year in Q4, with NGS revenue up 23%; five NGS products launched since 2023 contributed up to 25% of clinical revenue.
Expanded product portfolio with launches such as RaDaR ST MRD assay and PanTracer Pro, targeting high-growth oncology markets.
Sales force expansion and commercial execution increased penetration among community oncologists, with 75% of new oncologists ordering 5+ tests in 2025.
Net loss for Q4 decreased 36% to $10M, but full-year net loss increased 37% to $108M.
Financial highlights
Q4 adjusted gross profit increased by $5.8M (7–8%) to $83M, with adjusted EBITDA reaching $13.4M, up 10–13% year-over-year.
Full-year adjusted gross profit rose $23M (8%) to $335M, with an adjusted gross margin of 46%.
Adjusted EBITDA for 2025 was $43–43.4M, up 9% from prior year.
Free cash flow improved by $12M or 35–36% year-over-year; cash and equivalents at year-end totaled $160M.
Q4 average revenue per clinical test increased 5% to $488; 7% growth excluding Pathline.
Outlook and guidance
2026 revenue guidance: $793M–$801M, representing 9–10% growth; adjusted EBITDA expected between $55M–$57M, up 27–31% year-over-year.
Modest revenue contribution expected from RaDaR ST MRD assay and PanTracer LBx in 2026, with substantial long-term opportunity.
Quarterly revenue growth expected to be 10% in Q1, 8–9% in Q2, 9–10% in Q3, and slightly above 10% in Q4.
Gross margin expected to expand by 100–120 basis points in 2026, driving most of the adjusted EBITDA margin improvement.
2026 GAAP net loss projected at $63–$50M; adjusted net income $39–$36M.
Quantify RaDaR ST/LBx revenue upside from early MolDx
How will new sales reps specialize for RaDaR ST
Beyond 2026, what drives margin expansion
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next NeoGenomics earnings date
TD Cowen 46th Annual Health Care Conference3 Mar, 2026
NeoGenomics
Next NeoGenomics earnings date
TD Cowen 46th Annual Health Care Conference3 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
NeoGenomics Inc provides cancer-focused genetic testing services, including clinical and research laboratory diagnostics. The company offers molecular, cytogenetic, and flow cytometry testing to pathologists, oncologists, and pharmaceutical companies. It supports precision medicine and oncology drug development. The company is headquartered in Fort Myers, Florida, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage